Only recently have investigations into the precise roles of propranolol in IHs revealed that this therapy blocks hemangioma endothelial growth and this effect may be through suppressing the production of nitric oxide and HIF1α regulation of vascular endothelial growth factor (VEGF) expression (10,11). The gene discussed is VEGFA; the disease is hemangioma.